Comparing of GlaxoSmithKline plc (GSK) and Eli Lilly and Company (NYSE:LLY)
GlaxoSmithKline plc (NYSE:GSK) and Eli Lilly and Company (NYSE:LLY) compete with each other in the Drug Manufacturers – Major sector. We will analyze and compare their analyst recommendations, profitability, risk, dividends, institutional ownership, earnings and valuation. GlaxoSmithKline plc is thus currently the affordable of the two stocks because it has a lower price-to-earnings ratio. The information presented earlier suggests that GlaxoSmithKline plc looks more robust than Eli Lilly and Company as far as analyst view.